W0252
Anaerobic Crystal Structures of Biphenyl Dioxygenase and
its Complexes With Substrate and Product. Pravindra Kumar1,
Christopher L. Colbert1, Nathalie Y. R. Agar2, Lindsay D.
Eltis3, Justin Powloski2, and Jeffrey T.
Bolin1, 1Markey Center for Structural Biology, Dept. of
Biological Sciences, Purdue Univ., W Lafayette, IN 47907, USA; 2Dept.
of Chemistry and Biochemistry, Concordia Univ., Montreal, PQ, H3G 1M8, Canada;
3Depts. of Microbiology and Biochemistry, Univ. British Columbia,
Vancouver, BC, V6T 1Z3, Canada.
Improvements in purification and crystallization led to
determination of crystal structures for biphenyl dioxygenase, BPDO, from
Comamonas testosteroni strain B-356 and its complexes with substrate and
product at 1.5-1.6Å resolution in the presence of full complements of the
native metals. Comparisons of free enzyme with the complexes provide evidence
that the coordination of the Fe(II) site changes with the state of the enzyme.
The internal rearrangements of ligands may be required to avoid steric clashes
with substrate and product, may also be important for control of dioxygen
binding and activation, and may influence substrate preferences.
Biphenyl dioxygenase is the catalytic component from the
multicompon-ent biphenyl dioxygenase system. The other components include a
Rieske ferredoxin, which supplies electrons to BPDO, and a flavoprotein
ferredoxin reductase. This system catalyzes the first step in the aerobic
microbial degradation of biphenyl and some PCBs, and is targeted for
improvements to facilitate the bioremediation of PCBs. The chemistry typically
involves the dihydroxylation of an aromatic ring to generate a substituted
cis-cyclohexadienediol. BPDO is an
α3β3
hexamer (225 kDa) that binds one Rieske Fe-S cluster and one Fe(II) ion per
α subunit. Prior crystallographic studies of
BPDO were complicated by loss of Fe(II) from the active site.
Supported by NIH (R01-GM52381) and NSERC (224153-99), and
various agencies that support BioCARs and SBC at the Advanced Photon
Source.